Protocol: IXT5 - A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia
Status: Follow-up
Start Date: 12/19/2016
End Date:  
Clinical Trial ID: NCT02807350
Public Dataset:  

 



IXT5 - A Randomized Clinical Trial of Overminus Spectacle Therapy for Intermittent Exotropia

 

Protocol

Primary Objective:

  • The objective of this full-scale randomized trial comparing 2.50D overminus lens treatment vs. non-overminus (spectacles without overminus or no spectacles) is to determine the efficacy of overminus lenses after 12 months of treatment.
 


 



Back